Literature DB >> 16802339

Tumor necrosis factor-neutralizing therapies improve altered hormone axes: an alternative mode of antiinflammatory action.

Rainer H Straub1, Peter Härle, Piercarlo Sarzi-Puttini, Maurizio Cutolo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16802339     DOI： 10.1002/art.21946

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  10 in total

1.  Reproductive immunology: current status and future directions (part I).

Authors:  Elena Peeva
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

2.  Mathematical modeling of the circadian dynamics of the neuroendocrine-immune network in experimentally induced arthritis.

Authors:  R Rao; D DuBois; R Almon; W J Jusko; I P Androulakis
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-05-24       Impact factor: 4.310

3.  High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor alpha inhibitors in rheumatoid arthritis.

Authors:  Francesca Bobbio-Pallavicini; Roberto Caporali; Claudia Alpini; Stefano Avalle; Oscar M Epis; Catherine Klersy; Carlomaurizio Montecucco
Journal:  Ann Rheum Dis       Date:  2006-11-01       Impact factor: 19.103

4.  Activity of the neuroendocrine axes in patients with polymyalgia rheumatica before and after TNF-α blocking etanercept treatment.

Authors:  Frederik Flindt Kreiner; Henrik Galbo
Journal:  Arthritis Res Ther       Date:  2012-08-15       Impact factor: 5.156

5.  Large Scale Metabolic Profiling identifies Novel Steroids linked to Rheumatoid Arthritis.

Authors:  Noha A Yousri; Karim Bayoumy; Wessam Gad Elhaq; Robert P Mohney; Samar Al Emadi; Mohammed Hammoudeh; Hussein Halabi; Basel Masri; Humeira Badsha; Imad Uthman; Robert Plenge; Richa Saxena; Karsten Suhre; Thurayya Arayssi
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

6.  TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease.

Authors:  Renee E Vickman; LaTayia Aaron-Brooks; Renyuan Zhang; Nadia A Lanman; Brittany Lapin; Victoria Gil; Max Greenberg; Takeshi Sasaki; Gregory M Cresswell; Meaghan M Broman; J Sebastian Paez; Jacqueline Petkewicz; Pooja Talaty; Brian T Helfand; Alexander P Glaser; Chi-Hsiung Wang; Omar E Franco; Timothy L Ratliff; Kent L Nastiuk; Susan E Crawford; Simon W Hayward
Journal:  Nat Commun       Date:  2022-04-19       Impact factor: 17.694

Review 7.  Androgens in rheumatoid arthritis: when are they effectors?

Authors:  Maurizio Cutolo
Journal:  Arthritis Res Ther       Date:  2009-09-22       Impact factor: 5.156

8.  Infliximab for the treatment of plaque psoriasis.

Authors:  Jennifer S Gall; Robert E Kalb
Journal:  Biologics       Date:  2008-03

9.  Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study.

Authors:  Tuulikki Sokka; Sergio Toloza; Maurizio Cutolo; Hannu Kautiainen; Heidi Makinen; Feride Gogus; Vlado Skakic; Humeira Badsha; Tõnu Peets; Asta Baranauskaite; Pál Géher; Ilona Ujfalussy; Fotini N Skopouli; Maria Mavrommati; Rieke Alten; Christof Pohl; Jean Sibilia; Andrea Stancati; Fausto Salaffi; Wojciech Romanowski; Danuta Zarowny-Wierzbinska; Dan Henrohn; Barry Bresnihan; Patricia Minnock; Lene Surland Knudsen; Johannes Wg Jacobs; Jaime Calvo-Alen; Juris Lazovskis; Geraldo da Rocha Castelar Pinheiro; Dmitry Karateev; Daina Andersone; Sylejman Rexhepi; Yusuf Yazici; Theodore Pincus
Journal:  Arthritis Res Ther       Date:  2009-01-14       Impact factor: 5.156

10.  MHC/class-II-positive cells inhibit corticosterone of adrenal gland cells in experimental arthritis: a role for IL-1β, IL-18, and the inflammasome.

Authors:  Hubert Stangl; Anita Krammetsvogl; Martin Lesiak; Christine Wolff; Rainer H Straub
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.